Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physicians/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Two fully funded post-doctoral positions are available in the lab of Dr. Carl Novina in the Cancer Immunology and Virology Program at Dana-Farber Cancer Institute (http://novinalab.dana-farber.org/). The positions are available for the translation of (1) autologous T cell therapies for solid tumors including chimeric antigen receptors (CAR-T cells) and (2) targeted epigenetic reprogramming of immune cells.
Successful candidates will work in a collaborative and entrepreneurial team of researchers and clinicians to develop and evaluate the efficacy of novel cell and molecular therapies.
Interested individuals should submit a cover letter and curriculum vitae, including contact information for three references, to Dr. Carl Novina (NovinaLab@dfci.harvard.edu).
Candidates should have a PhD or MD/PhD in immunology or a related field and at least one first author peer-reviewed publications, with significant experience in standard immunological assays. Expertise in neuroimmunology, immunotherapy, and/or human immunobiolgy preferred.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.